UMECRINE Cognition signs partnering agreement with CleveXel Pharma

Posté le octobre 23, 2013 in Actualités, Presse -

October 23, 2013 – Umecrine Cognition AB, a Karolinska Development portfolio company, today announced that the company has entered into a partnering agreement with CleveXel Pharma regarding the development of its lead program in hepatic encephalopathy.
More +

About The Author